RegeneRx Biopharmaceuticals, Inc. RGRX
0.00 USD 0.00 0.00%
At close · Nov 2
0.0002 52-week range 0.163
- YTD
- +266.67%
- 1 year
- +450.00%
- Open
- 0.161
- Prev close
- 0.0011
- Mkt cap
- 1.65K
- Vol
- 252
- Avg vol
- 47
- EPS
- -0.71
- P/E
- 0.00
More statistics
- Low
- 0.161
- High
- 0.161
- Earnings
- Jan 2, 2023
MAX chart
Chart tools
Chart is warming up
The all-time price history for RGRX has not been loaded yet. Try again in a moment.
Altman Z-Score
-878.30 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -13.9×
P/S 25976×
P/B -579×
P/FCF -2120×
EV/EBITDA -221673881×
EV/Sales 25991×
FCF Yield -0.0%
Gross Margin 100.0%
Operating Margin -1826.4%
Net Margin -2249.8%
ROE 50.1%
ROIC 1094.4%
ROA -451.9%
Revenue 0.0%
Operating Income -5.5%
EPS (diluted) -7094.2%
Free Cash Flow 5.0%
Current Ratio 0.6×
Quick Ratio 0.6×
Debt / Equity -0.4×
Net Debt / EBITDA -128381×
Interest Coverage -4.3×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31